Inhibition of Naloxone‐Stimulated Adrenocorticotropin Release by Alprazolam in Myotonic Dystrophy Patients-Reference-Cited by-同舟云学术

Inhibition of Naloxone‐Stimulated Adrenocorticotropin Release by Alprazolam in Myotonic Dystrophy Patients

Published:1998-05 Issue:5 Volume:10 Page:391-395
ISSN:0953-8194
Container-title:Journal of Neuroendocrinology
language:en
Short-container-title:Journal of Neuroendocrinology

Author:

Joyner Julie M.¹,Grice Jeffrey E.¹,Hockings Gregory I.¹,Torpy David J.¹,Crosbie Georgina V.¹,Walters Margaret M.¹,Jackson Richard V.¹

Affiliation:

1. Neuroendocrine Research Unit, Department of Medicine, University of Queensland, Queensland, Australia.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2826.1998.00220.x

Reference31 articles.

1. COMMENTARY: Myotonic dystrophy reviewed: back to the future?

2. PSHarpered.Myotonic Dystrophy London: Saunders 1989.

3. RVJackson GAFleming CRSussman ABAtkinson GSDeCherney CRDeBold DRDavis WENicholson DPIsland DRabin GMFenichel WWVale DNOrthIncreased pro‐opiomelanocortin‐derived peptide release in myotonic dystrophyAust Paediatr J198824 (suppl. 1):7073

4. Myotonic dystrophy: an unstable CTG repeat in a protein kinase gene;Timchenko L;Cell Biol,1995

5. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare POMC Mutation in a Patient With Myotonic Dystrophy Type 1 and Adrenocorticotropin Hyperresponse to Corticotropin-Releasing Hormone;AACE Clinical Case Reports;2019-03

2. Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder;Psychopharmacology;2004-08-27

3. Interdose Elevation in Plasma Cortisol During Chronic Treatment with Alprazolam but not Lorazepam in the Elderly;Neuropsychopharmacology;2003-12-17

4. β-Phenylethylamines and the isoquinoline alkaloids (July 1998 to June 1999);Natural Product Reports;2000

5. Stimulatory and inhibitory regulators of the hypothalamo–pituitary–adrenocortical axis;Best Practice & Research Clinical Endocrinology & Metabolism;1999-12